Restless Legs Syndrome Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.A Follow-up Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome
Condition: Restless Legs Syndrome Interventions: Drug: Rotigotine 1 mg/24 h; Drug: Rotigotine 2 mg/24 h; Drug: Rotigotine 3 mg/24 h Sponsor: UCB Biopharma S.P.R.L. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 20, 2019 Category: Research Source Type: clinical trials
